ICD-10-CM Billable Code

F12.251

Cannabis dependence with psychotic disorder with hallucinations

Clinical Classification Guidelines

Medical Intelligence & Overview

ICD-10 code F12.251 refers to a condition characterized by cannabis dependence accompanied by a psychotic disorder featuring hallucinations. This condition involves a problematic relationship with cannabis, a substance derived from the Cannabis plant, combined with a mental health complication where an individual experiences hearing, seeing, or sensing things that aren't present. Recognizing and understanding this condition is essential for appropriate management and treatment.

Causes & Symptoms

Clinical Causes: Chronic or heavy cannabis use over an extended period Genetic predisposition to mental health disorders History of psychiatric illnesses in family members Environmental stressors or traumatic experiences Concurrent use of other psychoactive substances Pre-existing mental health vulnerabilities

Key Symptoms: Hallucinations, such as hearing voices or seeing things that aren’t there Persistent craving or compulsive use of cannabis despite negative consequences Withdrawal symptoms like irritability, anxiety, or sleep difficulties when not using cannabis Disorganized thoughts or speech Paranoia or suspiciousness Changes in mood, such as depression or agitation Impaired social or occupational functioning

Diagnostic & Treatment

Diagnosis Path: Diagnosing this condition involves a comprehensive clinical assessment, including patient history, mental health evaluation, and possibly physical examinations. Mental health professionals look for signs of cannabis dependence, which include a pattern of problematic use, withdrawal symptoms, and inability to control consumption. They also evaluate for psychotic symptoms like hallucinations and assess their relation to cannabis use. Standardized questionnaires and psychiatric interviews assist in confirming the diagnosis, with criteria aligning to ICD-10 guidelines.

Treatment Protocols: Treatment options generally involve a combination of approaches aimed at managing both the substance dependence and the psychotic symptoms: - **Detoxification programs** to safely reduce or cease cannabis use under medical supervision - **Psychotherapy**, such as cognitive-behavioral therapy (CBT), to address substance dependency and psychotic symptoms - **Medication management**, which may include antipsychotics to control hallucinations and other psychotic features - **Support groups** and ongoing counseling to reinforce recovery and prevent relapse - **Integrated treatment plans** tailored to individual needs, often involving coordinated mental health and substance abuse services Recovery involves ongoing support, medication adherence, and therapy to stabilize mental health and minimize the risk of relapse into dependence or psychosis.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is F12.251 a billable ICD-10 code?
Yes, F12.251 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report F12.251?
Clinical documentation must specify the nature of Cannabis dependence with psychotic disorder with hallucinations and any associated comorbidities for accurate reporting.

Cite this Clinical Reference